Documents tagged "Special"
Found 32 documents with this tag
HOUSE_OVERSIGHT_029304.txt
The document is a letter of recommendation from Donald Trump for Michael Bocci°. Trump has worked with Bocci° for three years and trusted him in personal and business endeavors. He praises Bocci°'s leadership skills, intelligence, and efficiency, saying that he would make any company or individual lucky enough to work alongside him more effective, efficient, and profitable.
HOUSE_OVERSIGHT_029302.txt
Michael J. Boccio worked at The Trump Organization as Managing Director of Business Development and Special Counsel from July 2008 to July 2011. He managed the global product licensing division, trademark portfolio, and legal team for Donald J. Trump, Ivanka Trump, and Melania brands. Additionally, he managed a home site development called The Estates at Trump National in California, was elected as a member of the HOA board, developed and executed the HOA budget, liaised with the California Department of Real Estate, gained approval for the 2010 subdivision report, hired and managed brokerage teams, developed a revised housing strategy for future development, and managed multiple negotiations and closings of homes. He also worked on developing a lease form for Trump International Chicago and negotiating leases, amendments, and term sheets for the retail space.
HOUSE_OVERSIGHT_029299.txt
The email is from Eric Roth to Jeffrey Epstein, discussing a person named Michael Boccio. Eric worked closely with Michael while refurbishing Donald Trump's 757 and was impressed by his intelligence, creativity, and abilities. He believes that someone or an organization would benefit greatly from having Michael on their team. Attached to the email are Michael's cover letter, resume, and a recommendation letter from Donald Trump.
HOUSE_OVERSIGHT_029165.txt
The Special Counsel's office is preparing for a potential confrontation with President Trump over alleged obstruction of justice and other matters related to the Russia investigation. Robert Mueller has reportedly been developing an aggressive legal strategy in response to the President's use of his pardon authority. Sources close to the investigation have provided information about the proposed charges against the president, although they would not speak on the record. The Special Counsel's office is known for its leak-proof nature and immunity to political pressure from the White House.
HOUSE_OVERSIGHT_029085.txt
David Grosof is in correspondence with Jeffrey E. discussing topics of interest including "distributions in nature," deception, sleep, power, money, and music's effect on the brain. They also touch upon neurophysiology and signal intelligence in biological systems, as well as productivity enhancing music apps and consciousness hacking. In addition, they discuss the potential for a national emergency due to the Trump-GOP's actions and how to respond to such an event.
HOUSE_OVERSIGHT_025185.txt
The document discusses probability and forces, with Jeffrey E. suggesting that probability is a force rather than just a statistical concept. He also mentions centrifugal force as an example of how forces can be perceived differently in different frames of reference. In the conversation, Jeffrey E. and David Grosof exchange ideas on these topics, with references to concepts such as regression to the mean, inertial reference frames, and the nature of probability.
HOUSE_OVERSIGHT_025180.txt
In this email exchange between Jeffrey E. and David Grosof, they discuss topics such as probability and central tendency, with a focus on the concept of an inertial reference frame for understanding abstract concepts like these. They also mention the works of James Watson and Francis Crick in their conversation. Both individuals are using smartphones to send these messages.
HOUSE_OVERSIGHT_025172.txt
The email conversation between Jeffrey E. and David Grosof touches on various topics such as probability, statistics, and forces in nature. It is suggested that probability can be viewed as a force similar to electromagnetism. The participants also discuss the ideas of James Watson, who is known for his work in genetics and molecular biology, and they mention having dinner with him.
HOUSE_OVERSIGHT_025169.txt
The document appears to be a series of emails discussing probability and its relation to various topics such as nature, signals, deception, sleep, power, money, music and the brain, and signal intelligence in biological systems. Key people mentioned include David Grosof, James Watson, Gunther Stent, Crick, and Jonathan Victor. The conversation also touches on a book tour at Google and dining with James Watson.
HOUSE_OVERSIGHT_018084.txt
This document discusses a special tax benefit for founders and investors of new startups and angel investing, which was enacted as part of a federal tax law provision. The benefit allows profits from investments in startup companies to be exempted from all federal income taxes under certain circumstances. This special tax benefit is applicable only to stock issued between September 28 and December 31, 2010, and has specific requirements for the founder or investor, such as holding shares of a qualified small business for at least five years. The document emphasizes that time is of the essence to take advantage of this tax benefit.
HOUSE_OVERSIGHT_015672.txt
Robin Solomon is an executive with over three decades of experience in academic medicine. She has combined her skills in patient care, clinical research, philanthropy and business development to build strategic alliances, institutional recognition and revenue. Her career includes roles at The Mount Sinai Medical Center where she served as Vice President for Special Projects and Vice President for Trustee Services. Throughout her career, Solomon is known for her ability to navigate the healthcare sector, collaborate with physicians and persuasively convey philanthropic opportunities to donors.
HOUSE_OVERSIGHT_013482.txt
This document discusses stem cell therapy in the United States and Europe. In the US, President Obama overturned an executive order prohibiting federal funding of human embryonic stem cell research, leading to increased momentum in this field. The first regulatory approval of a manufactured stem cell product has also been achieved. However, there are still challenges, such as a tough regulatory climate for biopharmaceuticals and legal challenges to the relaxing of rules on hESCs. In Europe, experts debate what must be done to maintain its lead in regenerative medicine and stem cell research.